Russell J Coleman

This inventor holds 23 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Recombinant Protein Engineering. Top assignees: Cp Kelco U.s., Inc., Pfenex Inc., Dow Global Technolgoies LLC. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Russell J Coleman. Retrieved from https://idiyas.com/inventor/russell-j-coleman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 4)

% Patents Active = 95.7

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 98(Granted Patents)

Location History:

Pomona, CA (US) (2004)
San Diego, CA (US) (2008 - 2022)

Company Filing History:

Dow Global Technolgoies LLC

patents

4. 1 out of 834,570

Other

patents

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Recombinant Protein

Bacterial Hosts

Gene Deletions

Heterologous Proteins

Diutan Gum

Polysaccharide Slime

Microbial Screening

Gellan Gum

Inflatable Structures

Protein Expression

Modified Organisms

High Viscosity

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12674172 - BACTERIAL HOSTS FOR RECOMBINANT PROTEIN EXPRESSION (2026-07-07),

2. 11377661 - Method for production of recombinantasparaginase (2022-07-05),

3. 11046964 - Method for production of recombinantasparaginase (2021-06-29),

4. 10787671 - Method for production of recombinant (2020-09-29),

5. 10689640 - Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins (2020-06-23),

6. 10662433 - Method for production of recombinantasparaginase (2020-05-26),

7. 10351858 - Targeted gene deletions for polysaccharide slime formers (2019-07-16),

8. 9926527 - Modified organisms for producing gums (2018-03-27),

9. 9845476 - Targeted gene deletions for polysaccharide slime formers (2017-12-19),

10. 9580719 - Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins (2017-02-28),

11. 9422567 - Targeted gene deletions for polysaccharide slime formers (2016-08-23),

12. 9394571 - Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins (2016-07-19),

13. 8921077 - Method of producing a diutan gum (2014-12-30),

14. 8759071 - Targeted gene deletions for polysaccharide slime formers (2014-06-24),

15. 8716003 - Targeted gene deletions for polysaccharide slime formers (2014-05-06),

Title: The Innovative Contributions of Russell J Coleman: Advancements in Recombinant Asparaginase Production

Introduction: Russell J Coleman, a notable inventor based in San Diego, California, has made significant contributions to the field of biotechnology, particularly in the production of recombinant asparaginase. With a remarkable portfolio of 21 patents, Coleman's work focuses on enhancing the efficiency and effectiveness of asparaginase production for therapeutic uses.

Latest Patents: Among his latest innovations is a patent titled "Method for Production of Recombinant Asparaginase," which outlines novel methodologies for producing asparaginase with high expression levels within host cells. This invention is particularly noteworthy as it ensures that the asparaginase produced shows activity comparable to commercially available preparations, thus pushing the boundaries of current biopharmaceutical practices.

Career Highlights: Throughout his career, Coleman has worked with prestigious institutions such as CP Kelco U.S., Inc. and Pfenex Inc., where he has utilized his expertise to drive innovative solutions in the field of biotechnology. His extensive experience has enabled him to navigate complex challenges in recombinant protein production, leading to improved therapeutic options for patients.

Collaborations: Coleman's collaborative efforts with esteemed colleagues such as Nancy E Harding and Yamini N Patel have further enriched his contributions. These partnerships exemplify the collaborative nature of scientific research, where shared knowledge and skills lead to groundbreaking advancements.

Conclusion: Russell J Coleman's dedication to innovation in recombinant asparaginase production showcases his importance in the biotechnology industry. His numerous patents reflect his commitment to enhancing therapeutic treatments and improving patient outcomes. As the field continues to evolve, Coleman's contributions remain pivotal in shaping the future of biopharmaceuticals.

Profile summary based on public USPTO records.